Expanding the Scope of Precision Care for Patients With HR-Positive Breast Cancers: Things You Should Know

Learn from expert faculty as they discuss application of recent clinical evidence to develop personalized treatment plans for HR-positive/HER2-negative early and advanced breast cancer the use of current and emerging oral targeted therapies and strategies to promote adherence with a downloadable slideset from a satellite symposium an on-demand webcast and expert commentary.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Lilly

Novartis Pharmaceuticals Corporation

Sanofi Genzyme